Agranulocytosis associated with carbamazepine, and a positive reaction with anti-lymphoid leukaemia antiserum during recovery
Open Access
- 1 September 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 56 (659) , 665-668
- https://doi.org/10.1136/pgmj.56.659.665
Abstract
Carbamazepine is a valuable drug in the treatment of trigeminal neuralgia and temporal lobe epilepsy. Rarely agranulocytosis has been described associated with its use but in this further non-fatal case a new finding of a positive reaction with anti-lymphoid leukaemia anti-serum was seen during the recovery phase. A brief review of 18 cases in the literature is provided and it is noted that 94% of reported cases are over the age of 45 years. The significance of the haematological finding is discussed.This publication has 18 references indexed in Scilit:
- Acute lymphoblastic leukaemia associated antigen. IV Expression on non-leukaemic ‘lymphoid’ cellsLeukemia Research, 1980
- No proven relationship of carbamazepine therapy to blood dyscrasiasNeurology, 1978
- TARGET CELL IN CHRONIC MYELOID LEUKÆMIA AND ITS RELATIONSHIP TO ACUTE LYMPHOID LEUKÆMIAThe Lancet, 1976
- Antisera to acute lymphoblastic leukemia cellsClinical Immunology and Immunopathology, 1975
- CarbamazepineAnnals of Internal Medicine, 1973
- TEGRETOL IN TRIGEMINAL NEURALGIA WITH SPECIAL REFERENCE TO HEMATOPOIETIC SIDE EFFECTSHeadache: The Journal of Head and Face Pain, 1969
- CLINICAL TRIALS OF TEGRETOL IN TRIGEMINAL NEURALGIAHeadache: The Journal of Head and Face Pain, 1969
- Carbamazepine in the Treatment of NeuralgiaArchives of Neurology, 1968
- Tic Douloureux Treated With New AnticonvulsantArchives of Neurology, 1963
- Detection and Prevention of Drug-Induced Blood DyscrasiasPublished by American Medical Association (AMA) ,1962